Beta-blockers, diuretics and physical fitness as determinants of serum lipids in myocardial infarction patients

References

• Brunner D, Weisbort J, Loebl K, Schwartz S, Altman S, Berman J E, Levin S. Serum cholesterol and high density lipoprotein‐cholesterol in coronary patients and healthy persons. Atherosclerosis 1979; 33: 9–16
   PubMedGoogle Scholar
• Kannel W B. Hypertension, blood lipids and cigarette smoking as co‐risk factors for coronary heart disease. Ann NY Acad Sci 1978; 304: 128–39
   PubMedGoogle Scholar
• Albers J J, Cheung M C, Hazzard W R. High‐density lipoproteins in myocardial infarction survivors. Metabolism 1978; 27: 479–85
   PubMed Web of Science ®Google Scholar
• Erkelens D W, Albers J J, Hazzard W R, Frederick R C, Bierman E L. High‐density lipoprotein‐cholesterol in survivors of myocardial infarction. J Amer Med Ass 1979; 242: 2185–9
   PubMed Web of Science ®Google Scholar
• Kaukola S, Manninen V, Halonen P I. Serum lipids with special reference to HDL cholesterol and triglycerides in young male survivors of acute myocardial infarction. Acta Med Scand 1980; 208: 41–3
   PubMedGoogle Scholar
• Barboriak J J, Anderson A J, Rimm A A, King J F. High density lipoprotein cholesterol and coronary artery occlusion. Metabolism 1979; 28: 735–8
   PubMed Web of Science ®Google Scholar
• Pearson T A, Bulkley B H, Achugg S C, Kwitero‐vich P O, Cordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidem 1979; 109: 285–95
   PubMed Web of Science ®Google Scholar
• Wieland H, Seidel D, Wiegand V, Kreuzer H. Serum lipoproteins and coronary artery disease (CAD). Comparison of the lipoproteins profile with the results of coronary angiography. Atherosclerosis 1980; 36: 269–80
   PubMed Web of Science ®Google Scholar
• Day J L, Simpson N, Metcalfe J, Page R L. Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Br Med J 1979; 1: 77–80
   PubMed Web of Science ®Google Scholar
• Shaw H, England J DF, Hua A SP. Beta‐blockers and plasma triglycerides. Br Med J 1978; 1: 986
   PubMed Web of Science ®Google Scholar
• Tanaka N, Sakaguchi S, Oshige K, Niimura T, Kanehisa T. Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 1976; 25: 1071–5
   PubMed Web of Science ®Google Scholar
• Lehtonen A, Viikari J. Long‐term effect of sotalol on plasma lipids. Clin Sci 1979; 57: 405–7
   Google Scholar
• Peden N R, Dow R J, Isles T E, Martin B T. Adrenoceptor blockade and responses of serum lipids to a meal and exercise. Br Med J 1984; 288: 1788–90
   PubMedGoogle Scholar
• Helgeland A, Hjermann I, Leren P, Enger S, Holme I. High‐density lipoprotein cholesterol and antihypertensive drugs; the Oslo study. Br Med J 1978; 2: 403
   PubMed Web of Science ®Google Scholar
• Streja D, Mymin D. Effect of propranolol on HDL cholesterol concentrations. Br Med J 1978; 2: 1495
   PubMed Web of Science ®Google Scholar
• Lehtonen A, Hietanen E, Marniemi J, Peltonen P, Nikkilä E. Effect of sotalol withdrawal on serum lipids and lipoprotein lipase activity. Int J Clin Pharmac Ther Toxic 1983; 21: 73–6
   PubMedGoogle Scholar
• Karmakoski J, Viikari J, Rönnemaa T. Effect of pindolol on serum lipoproteins in patients with coronary heart disease. Int J Clin Pharmac Ther Toxic 1983; 21: 189–91
   PubMedGoogle Scholar
• Lehtonen A, Hietanen E, Marniemi J, Peltonen P, Niskanen J. Effect of pindolol on serum lipids and lipid metabolizing enzymes. Br J Clin Pharmac 1982; 13: 445S–8S
   PubMedGoogle Scholar
• Durstine J L, Miller W, Farrell S, Sherman W M, Ivy J L. Increases in HDL‐cholesterol and HDL/LDL cholesterol ratio during prolonged endurance exercise. Metabolism 1983; 32: 993–7
   PubMed Web of Science ®Google Scholar
• Herbert P N, Bernier D N, Cullihane E M, Edelstein L, Kantor M A, Thompson P D. High‐density lipoprotein metabolism in runners and sedentary men. J Amer Med Ass 1984; 252: 1034–7
   Google Scholar
• Huttunen J K, Länsimies E, Voutilainen E, Ehnholm C, Hietanen E, Penttila I, Siitonen O, Rauramaa R. Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high‐density lipoproteins. Circulation 1979; 60: 1220–9
   PubMed Web of Science ®Google Scholar
• Lehtonen A, Viikari J. Serum lipids in soccer and ice‐hockey players. Metabolism 1979; 29: 36–9
   Google Scholar
• Moore C E, Hartung H, Mitchell R E, Kappus C M, Hinderlitter J. The relationship of exercise and diet on high‐density lipoprotein cholesterol levels in women. Metabolism 1983; 32: 189–96
   PubMed Web of Science ®Google Scholar
• Nikkilä E A, Taskinen M R, Rehunen S, Härkonen M. Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism 1978; 27: 1661–71
   PubMed Web of Science ®Google Scholar
• Peltonen P, Marniemi J, Hietanen E, Vuori I, Ehnholm C. Changes in serum lipids, lipoproteins, and heparin‐releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metabolism 1981; 27: 518–26
   Google Scholar
• Smith M, Mendez J, Druckenmiller M, Krisetherton P M. Exercise intensity dietary intake and high‐density lipoprotein cholesterol in young female competitive swimmers. Am J Clin Nutr 1982; 36: 251–5
   PubMed Web of Science ®Google Scholar
• Stubbe I, Hansson P, Gustafson A, Nilssonehle P. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high‐density lipoprotein subtractions and compositions. Metabolism 1983; 32: 1120–8
   PubMedGoogle Scholar
• Thompson P D, Lazarus B, Cullinane E, Henderson L D, Musliner T, Eshleman R, Herbert P N. Exercise, diet or physical characteristics as determinants of HDL‐levels in endurance athletes. Atherosclerosis 1983; 46: 333–9
   PubMed Web of Science ®Google Scholar
• Wood P D, Haskell W L, Blair S N, Williams P T, Krauss R M, Lindgren F T, Albers J J, Ho P H, Farquhar J W. Increased exercise level and plasma lipoprotein concentrations: a one‐year, randomized, controlled study in sedentary, middleaged men. Metabolism 1983; 32: 31–9
   PubMed Web of Science ®Google Scholar
• Kavanagh T, Shephard R J, Lindley L J, Pieper M. Influence of exercise and life‐style variables upon high density lipoprotein cholesterol after myocardial infarction. Arteriosclerosis 1983; 3: 249–59
   PubMedGoogle Scholar
• Wahlefeld A W. Triglycerides. Determination after enzymatic hydrolysis. Methods of enzymatic analysis2nd edition, H V Bergmeyer. Verlag Chemie and Academic Press, New York 1975; 1831–5
   Google Scholar
• Röschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum, using peroxydase as indicating enzyme. Abstract 9th Int Congr Clin Chem, Toronto, PI. Ann Clin Biochem 1975; 6: 24
   Google Scholar
• Kostner G M. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by poly‐anion precipitation. Clin Chem 1976; 22: 695
   PubMed Web of Science ®Google Scholar
• Lewis B. The lipoproteins: predictors, protectors and pathogens. Br Med J 1983; 287: 1161–4
   PubMed Web of Science ®Google Scholar
• Cardus D, McTaggart W G, Ribas‐Cardus F. Exercise training in ischaemic heart disease: effect of physical performance and plasma lipids, ACTH and Cortisol. Arch Phys Med Rehabil 1980; 61: 303–10
   PubMedGoogle Scholar
• Bassett Frey M A, Doerr B M, Lauback L L, Mann B L, Glueck C J. Exercise does not change high‐density lipoprotein cholesterol in women after ten weeks of training. Metabolism 1982; 31: 1142–6
   PubMedGoogle Scholar
• Shephard R J, Youldon P E, Cox M, West C. Effect of a 6‐month industrial fitness programme on serum lipid concentrations. Atherosclerosis 1980; 35: 277–86
   PubMed Web of Science ®Google Scholar
• Rönnemaa T, Viikari J, Irjala K, Peltola O. Marked decrease in serum HDL cholesterol level during acute myocardial infarction. Acta Med Scand 1980; 289: 161–6
   Google Scholar
• Oliver M F. Why measure cholesterol after myocardial infarction, and when?. Br Med J 1984; 289: 1641–2
   PubMedGoogle Scholar
• Bauer J H, Brooks C S, Weinstein J, Wilcox H H, Heimberg M, Burch R N, Barkley R. Effects of diuretics and propranolol on plasma lipoprotein lipids. Clin Pharmac Ther 1981; 20: 35–43
   Google Scholar
• Schauer I, Schauer U, Rühling K, Thielman K. The effect of propranolol treatment on total cholesterol, HDL cholesterol, triglycerides, post‐heparin lipolytic activity and lecithin: cholesterol acyltransferase in hypertensive individuals. Artery 1980; 8: 146–50
   PubMedGoogle Scholar
• Stamford B A, Matter S, Fell R D, Sady S, Papanek P, Cresanta M. Cigarette smoking, exercise and high density lipoprotein cholesterol. Atherosclerosis 1984; 52: 73–83
   PubMedGoogle Scholar
• Norwegian Multicenter Study Group. Timololinduced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801–7
   PubMed Web of Science ®Google Scholar